Functional nanosome for enhanced mitochondria-targeted gene delivery and expression
- PMID: 28669809
- DOI: 10.1016/j.mito.2017.06.005
Functional nanosome for enhanced mitochondria-targeted gene delivery and expression
Abstract
Mitochondria dysfunction plays a role in many human diseases. Therapeutic techniques for these disorders require novel delivery systems that can specifically target and penetrate mitochondria. In this study, we report a novel nanosome composed of dequalinium-DOTAP-DOPE (1,2 dioleoyl-3-trimethylammonium-propane-1,2-dioleoyl-sn-glycero-3-phosphoethanolamine) (DQA80s) as a potential mitochondria-targeting delivery vector. The functional DQAsome, DQA80s, showed enhanced transfection efficiency compared to a vector DQAsomes in HeLa cells and dermal fibroblasts. In addition, DQA80s/pDNA complexes exhibited rapid escape from the endosome into the cytosol. We observed the delivery of pDNA to mitochondria in living cells using flow cytometry, confocal microscopy, and TME imaging. More specifically, we confirmed our results by co-localization of hmtZsGreen constructs to mitochondria when delivered via DQAsomes and DQA80s in living cells. The mitochondria-targeting DQAsomes and DQA80s induced mitochondrial dysfunction through depolarization of mitochondrial membrane potential. Our data demonstrate that DQA80s show promise for use as a mitochondria-targeted carrier system for treatment of mitochondria diseases in vivo.
Keywords: Dequalinium; Gene delivery; Mitochondria; Mitochondria-targeting; hmtZsGreen.
Copyright © 2017. Published by Elsevier B.V.
Similar articles
-
Dequalinium-based functional nanosomes show increased mitochondria targeting and anticancer effect.Eur J Pharm Biopharm. 2018 Mar;124:104-115. doi: 10.1016/j.ejpb.2017.12.013. Epub 2018 Jan 2. Eur J Pharm Biopharm. 2018. PMID: 29305141
-
DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells.J Control Release. 2003 Sep 19;92(1-2):189-97. doi: 10.1016/s0168-3659(03)00297-9. J Control Release. 2003. PMID: 14499196
-
DQAsomes as the Prototype of Mitochondria-Targeted Pharmaceutical Nanocarriers : An Update.Methods Mol Biol. 2021;2275:13-25. doi: 10.1007/978-1-0716-1262-0_2. Methods Mol Biol. 2021. PMID: 34118029
-
Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems.J Control Release. 2016 Aug 28;236:1-14. doi: 10.1016/j.jconrel.2016.06.023. Epub 2016 Jun 15. J Control Release. 2016. PMID: 27317365 Review.
-
Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43. doi: 10.1016/j.ejpb.2013.07.002. Epub 2013 Jul 17. Eur J Pharm Biopharm. 2013. PMID: 23872180 Review.
Cited by
-
Recent Updates on the Efficacy of Mitocans in Photo/Radio-therapy for Targeting Metabolism in Chemo/Radio-resistant Cancers: Nanotherapeutics.Curr Med Chem. 2025;32(11):2156-2182. doi: 10.2174/0109298673259347231019121757. Curr Med Chem. 2025. PMID: 38018190 Review.
-
Innovative Biotherapies and Nanotechnology in Osteoarthritis: Advancements in Inflammation Control and Cartilage Regeneration.Int J Mol Sci. 2024 Dec 13;25(24):13384. doi: 10.3390/ijms252413384. Int J Mol Sci. 2024. PMID: 39769149 Free PMC article. Review.
-
Recent Advances in Mitochondria-Targeted Gene Delivery.Molecules. 2018 Sep 11;23(9):2316. doi: 10.3390/molecules23092316. Molecules. 2018. PMID: 30208599 Free PMC article. Review.
-
Delivery Systems for Mitochondrial Gene Therapy: A Review.Pharmaceutics. 2023 Feb 8;15(2):572. doi: 10.3390/pharmaceutics15020572. Pharmaceutics. 2023. PMID: 36839894 Free PMC article. Review.
-
Nanotechnology-Boosted Biomaterials for Osteoarthritis Treatment: Current Status and Future Perspectives.Int J Nanomedicine. 2023 Sep 4;18:4969-4983. doi: 10.2147/IJN.S423737. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37693887 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources